PMID- 12375740 OWN - NLM STAT- MEDLINE DCOM- 20030327 LR - 20191106 IS - 0892-3973 (Print) IS - 0892-3973 (Linking) VI - 24 IP - 3 DP - 2002 Aug TI - Anti-allergic effects of Sanguisorba officinalis on animal models of allergic reactions. PG - 455-68 AB - We investigated the effect of aqueous extract of Sanguisorba officinalis L.(Rosaceae) root (SOAE) on the immediate-type allergic reactions in vivo and in vitro. SOAE (0.01 to 1 g/kg) inhibited systemic allergic reaction induced by compound 48/80. When SOAE was employed in a systemic allergic reaction test, the plasma histamine levels were reduced in a dose-dependent manner. SOAE (0.001 to 1 g/kg) dose-dependently inhibited passive cutaneous anaphylaxis (PCA) activated by anti-dinitrophenyl (DNP) IgE. SOAE (0.001 to 1 mg/mL) also dose-dependently inhibited the histamine release from rat peritoneal mast cells (RPMC) activated by compound 48/80 or anti-DNP IgE. The level of cyclic AMP (cAMP) in RPMC, When SOAE was added, significantly increased compared with that of normal control. Moreover, SOAE (0.01 to 1 mg/mL) had a significant inhibitory effect on anti-DNP IgE-induced tumor necrosis factor-alpha (TNF-alpha) production. These results suggest that SOAE may be beneficial in the regulation of immediate-type allergic reaction. FAU - Shin, Tae-Yong AU - Shin TY AD - College of Pharmacy, Woosuk University, Chonju, Chonbuk, South Korea. FAU - Lee, Kyeong-Bo AU - Lee KB FAU - Kim, Sang-Hyun AU - Kim SH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Immunopharmacol Immunotoxicol JT - Immunopharmacology and immunotoxicology JID - 8800150 RN - 0 (Plant Extracts) RN - 0 (Tumor Necrosis Factor-alpha) RN - 4091-50-3 (p-Methoxy-N-methylphenethylamine) SB - IM MH - Animals MH - Histamine Release/drug effects MH - Hypersensitivity/*drug therapy MH - Male MH - Mice MH - Mice, Inbred ICR MH - *Phytotherapy MH - Plant Extracts/*therapeutic use MH - Rats MH - Rats, Sprague-Dawley MH - *Sanguisorba MH - Tumor Necrosis Factor-alpha/biosynthesis MH - p-Methoxy-N-methylphenethylamine/pharmacology EDAT- 2002/10/12 04:00 MHDA- 2003/03/28 05:00 CRDT- 2002/10/12 04:00 PHST- 2002/10/12 04:00 [pubmed] PHST- 2003/03/28 05:00 [medline] PHST- 2002/10/12 04:00 [entrez] AID - 10.1081/iph-120014729 [doi] PST - ppublish SO - Immunopharmacol Immunotoxicol. 2002 Aug;24(3):455-68. doi: 10.1081/iph-120014729.